Cargando…
Efficacy of Low-dose Dapagliflozin in Young People with Type 1 Diabetes
OBJECTIVE: Young people with type 1 diabetes are likely to gain body weight and not achieve optimal glycemic control with only high doses of insulin. This study examined the efficacy of the sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin as an adjunct-to-insulin therapy in young Japan...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Japanese Society of Internal Medicine
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908403/ https://www.ncbi.nlm.nih.gov/pubmed/36642532 http://dx.doi.org/10.2169/internalmedicine.9632-22 |